Answers are grounded in this paper and cite their sources.
Advances in Next-Generation Sequencing technologies (NGS) are revealing germline and somatic mutations that, together with karyotype, determine the diagnosis and subtype of Acute Myeloid Leukemia (AML).
No takes yet. Share an insight, caveat, or question.
Ruth et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: